The MAMA Study

Call Website Contact the practice

The MAMA Study MAMA is a research study designed to understand whether women with arthritis should continue biologics throughout pregnancy.

The MAMA Team are at the National Axial Spondyloarthritis Society Conference today in Birmingham! Please come and say he...
14/11/2026

The MAMA Team are at the National Axial Spondyloarthritis Society Conference today in Birmingham! Please come and say hello, and grab a sweet and some information about MAMA. You can find out more about the study and how you can take part at www.npeu.ox.ac.uk/mama/participants 💜

The National Perinatal Epidemiology Unit (NPEU) is a multidisciplinary research unit based at the University of Oxford. Our work involves running randomised con

50 participants are now taking part in the MAMA Study!Thank you to the women who have joined us; we greatly appreciate y...
30/10/2026

50 participants are now taking part in the MAMA Study!

Thank you to the women who have joined us; we greatly appreciate your participation. Thank you to the teams at OUH Maternity , St George's, Epsom and St Helier University Hospitals, Cardiff and Vale University Health Board , and Maternity at Guy's & St Thomas' for
supporting the women we have recruited recently 😊

The MAMA Study is designed to find out whether it is better for women who have inflammatory arthritis and are pregnant to temporarily stop or to continue taking biologic medications.

Both continuing and stopping the use of biologics beyond 28 weeks of pregnancy are routine practice in the UK; this varies between hospitals. The MAMA Study is looking to provide an answer on which is the better approach.

Visit the link in our bio to find out more about MAMA and how you can join the study, and follow us here for regular updates!

Congratulations to Agata Murgano, Clinical Research Nurse at St George's, Epsom and St Helier Hospitals Group, and the r...
23/10/2026

Congratulations to Agata Murgano, Clinical Research Nurse at St George's, Epsom and St Helier Hospitals Group, and the rest of the MAMA Team for helping MAMA recruit 3 women over the past few weeks! Thank you for your hard work, and a huge thank you to the women for taking part.

The MAMA Study is designed to find out whether it is better for women who have inflammatory arthritis and are pregnant to temporarily stop or to continue taking biologic medications.

Both continuing and stopping the use of biologics beyond 28 weeks of pregnancy are routine practice in the UK; this varies between hospitals. The MAMA Study is looking to provide an answer on which is the better approach.

You don’t have to be receiving care at a MAMA Recruiting Site to take part.

Visit https://www.npeu.ox.ac.uk/mama/participants to find out more about MAMA and how you can join the study. Follow us here for regular updates!

On  , the MAMA Trial team is proud to highlight our ongoing research into improving care for pregnant women living with ...
12/10/2026

On , the MAMA Trial team is proud to highlight our ongoing research into improving care for pregnant women living with inflammatory arthritis.

The MAMA Study is designed to find out whether it is better for women who have inflammatory arthritis and are pregnant to temporarily stop or to continue taking biologic medications.

Both continuing and stopping the use of biologics beyond 28 weeks of pregnancy are routine practice in the UK; this varies between hospitals. The MAMA Study is looking to provide an answer on which is the better approach.

Visit www.npeu.ox.ac.uk/mama/participants to find out more about MAMA and how you can join the study.

On  , the MAMA Trial team is proud to highlight our ongoing research into improving care for pregnant women living with ...
12/10/2026

On , the MAMA Trial team is proud to highlight our ongoing research into improving care for pregnant women living with inflammatory arthritis.

The MAMA Study is designed to find out whether it is better for women who have inflammatory arthritis and are pregnant to temporarily stop or to continue taking biologic medications.

Both continuing and stopping the use of biologics beyond 28 weeks of pregnancy are routine practice in the UK; this varies between hospitals. The MAMA Study is looking to provide an answer on which is the better approach.

Visit the link in our bio to find out more about MAMA and how you can join the study.

Could you help with The Wren Project’s survey? If you are a woman living with autoimmune disease and if childbearing age...
30/09/2026

Could you help with The Wren Project’s survey? If you are a woman living with autoimmune disease and if childbearing age you are invited to share your experiences of making decisions about pregnancy, breastfeeding, treatment and your own health.

You can find the link to complete the survey in their bio 💙

We need your help - If you're a women of childbearing age living with an autoimmune disease, please take a couple of minutes to complete our survey 👇

We’re gathering experiences of making decisions about pregnancy, breastfeeding, treatment and your own health.

The aim is to help clinicians, researchers and others working in the autoimmune disease field to better understand what women experience. If this applies to you, we’d really value your perspective.

Please take the survey and share it into any disease-specific Facebook groups you're in to reach others who could take part. Thank you.

Survey link: https://docs.google.com/forms/d/e/1FAIpQLSd-k5UTXP-rImEChynuPb1XcCRWs6thEtuvUdG4BpEeNJNgDQ/viewform

16/09/2026

We woke up as the sun rose this morning to attend the 3rd day of the International Clinical Trials Methodology Conference 2026 . The Team were proud to be showcasing MAMA in a poster presentation. Such a fantastic inspiring event to be part of!

Find out what’s in a MAMA Welcome Pack! Each participant in MAMA will be sent a Welcome Pack stuffed with items to help ...
09/09/2026

Find out what’s in a MAMA Welcome Pack! Each participant in MAMA will be sent a Welcome Pack stuffed with items to help you during your time in the study.

The MAMA Study is designed to find out whether it is better for women who have inflammatory arthritis and are pregnant to temporarily stop or to continue taking biologic medications.

Both continuing and stopping using biologics beyond 28 weeks of pregnancy are routine practice in the UK; this varies between hospitals. The MAMA Study is looking to provide an answer on which is the better approach.

Visit the link in our bio to find out more about MAMA and how you can join, and follow us here for regular updates!

We are hugely grateful for the support of some wonderful networks and charities, including Arthur's Place, a digital mag...
02/09/2026

We are hugely grateful for the support of some wonderful networks and charities, including Arthur's Place, a digital magazine and social network for young adults with arthritis. Thank you for your support Arthur's Place!

I wanted to start a family straight after getting married, so it was important that I find out how to do that safely on my arthritis medication.

Address

National Perinatal Epidemiology Unit CTU
Oxford
OX37LF

Alerts

Be the first to know and let us send you an email when The MAMA Study posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The MAMA Study:

Shortcuts

Share